top of page

Instituut voor Landbouw-, Visserij- en Voedingsbedrijven (ILVO) 

ILVO is a multidisciplinary, independent research institute that contributes to innovation, services and policy support in agriculture, fisheries and food in Flanders. The Aquatic Environment and Quality unit, based in Ostend, focuses mainly on the impact of human activities on the biological and chemical status of the marine environment, the quality of fish products, and the development and implementation of blue biotechnology.

​

​

​

University of Antwerp (UA) - Cell Death Signaling & Epigenetics lab

Epigenetic Signaling is a research team within the Cell Death Signaling research group at the University of Antwerp. The team focuses mainly on the effects of natural bioactive compounds on the epigenome and cellular signalling pathways, using omics techniques such as transcriptomics and chemoproteomics combined with systems biology to map their molecular mechanisms of action and targets.

​

​

​

Vrije Universiteit Brussel (VUB) - Liver Cell Biology)

LIVR (Liver Cell Biology) is a research group at the Vrije Universiteit Brussel (VUB) dedicated to fundamental and applied liver research. The group focuses mainly on the regulation of hepatic stellate cells and the development of in vitro liver models, ranging from 2D cell lines to advanced 3D models, to study liver fibrosis and other liver diseases and to identify new therapeutic targets.

​

​

​

Partners

Project Information

The Alga-Care consortium aims to unlock the untapped potential of microalgae by discovering, optimizing and valorizing novel bioactive compounds for health-promoting applications, with a primary focus on preventing liver disease — specifically metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic and alcohol-associated liver disease (MetALD). The project combines augmented bioactive production in microalgae, advanced in vitro screening, comprehensive chemical characterization, in vivo validation and targeted liver delivery technologies, bridging marine biotechnology with medical application​.

​

This project focuses on the following key objectives:

  • Discovering bioactive compounds from microalgae that could help prevent or treat fatty liver disease

  • Assembling a diverse library of algal strains, characterizing their chemical composition, and screening them for promising activity

  • Evaluating the most promising extracts across a range of liver disease models

  • Uncovering how these compounds work, how safe they are, and how they could be applied

  • Paving the way for further development into a nutraceutical, food supplement, or pharmaceutical product

  • Sharing the generated knowledge openly to support further research and other applications

​

​

FINANCING

Met de financiële steun van Vlaams Agentschap Innoveren & Ondernemen (VLAIO) 

TIme

April 2026 - maart 2029

VLAIO_sponsorlogo_vol.png
bottom of page